| Clinical Study of Venetoclax Combined With Azacytiside in the Treatment of Myelodysplastic/Myeloproliferative Neoplasms in Adults (NCT05282719) | The First Affiliated Hospital of Soochow University | 2022-04-01 |
| Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia (NCT01484015) | Wake Forest University Health Sciences | 2011-02-01 |
| Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant (NCT01118013) | Alliance for Clinical Trials in Oncology | 2010-12-01 |
| INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease (NCT01164163) | Children's Oncology Group | 2010-09-01 |
| Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation (NCT01116232) | Barbara Ann Karmanos Cancer Institute | 2010-08-01 |
| Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome (NCT00946283) | Rutgers, The State University of New Jersey | 2010-03-01 |
| Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant (NCT01077440) | Vanderbilt University | 2010-02-01 |
| 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer (NCT00935090) | Barbara Ann Karmanos Cancer Institute | 2009-09-01 |
| Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies (NCT00908167) | St. Jude Children's Research Hospital | 2009-09-01 |
| Registry of Older Patients With Cancer (NCT01137825) | UNC Lineberger Comprehensive Cancer Center | 2009-09-01 |
| Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer (NCT01137643) | UNC Lineberger Comprehensive Cancer Center | 2009-07-01 |
| Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer (NCT00726830) | M.D. Anderson Cancer Center | 2009-03-01 |
| Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer (NCT00823524) | Asan Medical Center | 2009-01-01 |
| Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment (NCT00800150) | City of Hope Medical Center | 2008-11-01 |
| Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers (NCT00952185) | City of Hope Medical Center | 2008-11-01 |
| American Ginseng in Treating Patients With Fatigue Caused by Cancer (NCT00719563) | Alliance for Clinical Trials in Oncology | 2008-10-01 |
| Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder (NCT00755040) | Vanderbilt-Ingram Cancer Center | 2008-10-01 |
| Blood Samples From Patients on a Clinical Trial to CINV During HSCT (NCT00900068) | OHSU Knight Cancer Institute | 2008-08-01 |
| A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families (NCT00782145) | Tufts Medical Center | 2008-06-01 |
| Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers (NCT00770419) | Rutgers, The State University of New Jersey | 2008-05-01 |
| Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes (NCT00624936) | Ohio State University Comprehensive Cancer Center | 2008-04-01 |
| Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial (NCT00750009) | Case Comprehensive Cancer Center | 2008-04-01 |
| Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer (NCT00516503) | Alliance for Clinical Trials in Oncology | 2008-02-01 |
| Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant (NCT00513474) | Massachusetts General Hospital | 2008-01-01 |
| Studying Fentanyl in Patients With Cancer (NCT00899951) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-10-01 |
| Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer (NCT00589563) | City of Hope Medical Center | 2007-05-01 |
| Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer (NCT00806767) | Institut Paoli-Calmettes | 2007-03-01 |
| Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant (NCT00900406) | Vanderbilt-Ingram Cancer Center | 2007-01-01 |
| Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant (NCT00964821) | City of Hope Medical Center | 2007-01-01 |
| T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant (NCT00651716) | Vanderbilt-Ingram Cancer Center | 2006-12-01 |
| Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes (NCT00045305) | Eastern Cooperative Oncology Group | 2006-10-24 |
| Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases (NCT00376922) | Wake Forest University Health Sciences | 2006-06-01 |
| Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00085449) | Alliance for Clinical Trials in Oncology | 2006-05-01 |
| Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant (NCT00324324) | OHSU Knight Cancer Institute | 2006-05-01 |
| Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer (NCT00281879) | OHSU Knight Cancer Institute | 2006-02-01 |
| 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes (NCT00301938) | National Cancer Institute (NCI) | 2005-12-01 |
| VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia (NCT00083187) | Vion Pharmaceuticals | 2005-11-01 |
| A Standardized Nursing Intervention Protocol for HCT Patients (NCT00951626) | City of Hope Medical Center | 2005-09-01 |
| Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease (NCT00462657) | St. Bartholomew's Hospital | 2005-07-01 |
| Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer (NCT00245037) | OHSU Knight Cancer Institute | 2005-06-01 |
| Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain (NCT00666211) | Vanderbilt-Ingram Cancer Center | 2005-05-01 |
| Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia (NCT00295997) | University of California, San Francisco | 2005-05-01 |
| Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders (NCT00114257) | National Cancer Institute (NCI) | 2005-05-01 |
| Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer (NCT00104975) | Yale University | 2005-02-01 |
| Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes (NCT00098683) | Children's Oncology Group | 2005-01-01 |
| Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes (NCT00104806) | Wake Forest University Health Sciences | 2004-11-01 |
| Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant (NCT00293384) | Barbara Ann Karmanos Cancer Institute | 2004-10-01 |
| Collecting and Storing Blood Samples From Patients With Cancer (NCT00900120) | University of Medicine and Dentistry of New Jersey | 2004-03-01 |
| T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies (NCT00080925) | National Institutes of Health Clinical Center (CC) | 2004-02-01 |
| Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes (NCT00072475) | Alliance for Clinical Trials in Oncology | 2003-12-01 |
| Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer (NCT00255684) | University of Rochester | 2003-12-01 |
| Cholecalciferol in Treating Patients With Myelodysplastic Syndrome (NCT00068276) | Wake Forest University Health Sciences | 2003-07-01 |
| Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy (NCT00066599) | National Cancer Institute (NCI) | 2003-06-01 |
| Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation (NCT00064311) | National Institutes of Health Clinical Center (CC) | 2003-06-01 |
| 3-AP and Cytarabine in Treating Patients With Hematologic Cancer (NCT00064090) | Vion Pharmaceuticals | 2003-03-01 |
| Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer (NCT00627666) | Asan Medical Center | 2003-01-01 |
| Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia (NCT00053157) | Roswell Park Cancer Institute | 2002-06-01 |
| FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma (NCT00042822) | Memorial Sloan Kettering Cancer Center | 2002-05-01 |
| Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer (NCT00062231) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-04-01 |
| VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome (NCT00049686) | Vion Pharmaceuticals | 2002-04-01 |
| Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation (NCT00036712) | Medical College of Wisconsin | 2002-01-01 |
| Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome (NCT00030550) | Roswell Park Cancer Institute | 2001-09-01 |
| Bevacizumab in Treating Patients With Myelodysplastic Syndrome (NCT00022048) | Stanford University | 2001-08-01 |
| Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer (NCT00028730) | Memorial Sloan Kettering Cancer Center | 2001-08-01 |
| Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00027560) | Memorial Sloan Kettering Cancer Center | 2001-07-01 |
| Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome (NCT00053001) | Fallon Clinic | 2001-06-01 |
| Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes (NCT00020969) | CTI BioPharma | 2001-03-01 |
| Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer (NCT00014469) | Memorial Sloan Kettering Cancer Center | 2000-12-01 |
| Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer (NCT00014495) | Memorial Sloan Kettering Cancer Center | 2000-11-01 |
| Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia (NCT00006040) | Memorial Sloan Kettering Cancer Center | 2000-04-01 |
| Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant (NCT00716911) | City of Hope Medical Center | 2000-01-01 |
| Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia (NCT00004245) | Memorial Sloan Kettering Cancer Center | 1999-08-01 |
| Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer (NCT00019656) | National Cancer Institute (NCI) | 1999-08-01 |
| Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome (NCT00003593) | Children's Oncology Group | 1999-06-01 |
| S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer (NCT00919425) | SWOG Cancer Research Network | 1999-04-01 |
| Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT00005823) | Leukemia Research Fund | 1998-12-01 |
| Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia (NCT00008164) | Herbert Irving Comprehensive Cancer Center | 1997-01-01 |
| Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00008216) | Columbia University | 1996-07-01 |
| Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders (NCT00005622) | H. Lee Moffitt Cancer Center and Research Institute | 1996-05-01 |
| Interleukin-2 in Treating Patients With Myelodysplastic Syndrome (NCT00002746) | University of Washington | 1996-01-01 |
| T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia (NCT00002718) | Memorial Sloan Kettering Cancer Center | 1995-11-01 |
| Bone Marrow Transplant in Treating Patients With Hematologic Cancers (NCT00005797) | H. Lee Moffitt Cancer Center and Research Institute | 1993-03-01 |
| S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers (NCT00996047) | SWOG Cancer Research Network | 1991-07-01 |
| Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma (NCT00900055) | OHSU Knight Cancer Institute | 1975-06-01 |
| Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies (NCT01101412) | M.D. Anderson Cancer Center | |